Improvement metrics involve its pharmacological properties and adjuvant role in treatment.
Analysis presented assessment using clinical outcomes related to acute kidney injury in diverse populations.
This insight highlights the need for further exploration into novel uses for existing medications, which could enhance kidney health.
Abstract
Valproate has pharmacological properties that point to its potential repositioning as an adjuvant in improving several outcomes in AKI and potentially avoiding progression to chronic kidney disease.
Ask AI
Helpful
Bookmark
Share
View Full Paper
Cite This Study
Alves‐Bezerra et al. (2026) studied this question.